Study guide
9.1 Pediatric Oncology & HSCT Nutrition
Board Certified Specialist in Pediatric Nutrition CSP
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 CSP Exam Facts, Format & Fees 1.2 Eligibility & Application Process 1.3 Scoring, Test Day Logistics & Study Strategy
2 Pediatric Growth & Development
2.1 Growth Patterns Across Pediatric Age Bands 2.2 Developmental Milestones & Feeding Skill Acquisition
3 Human Milk & Infant Formulas
3.1 Human Milk & Lactation Management 3.2 Milk Handling, Storage, Donor Milk & Fortification 3.3 Infant & Specialized Formulas
4 Age-Appropriate Nutrition & Foods
4.1 Complementary Feeding & Toddler Nutrition 4.2 School-Age & Adolescent Nutrition
5 Prematurity & the NICU Graduate
5.1 Preterm Nutrition in the NICU 5.2 Post-Discharge Nutrition for Preterm Infants
6 Congenital, Developmental & Metabolic Conditions
6.1 Congenital & Neurodevelopmental Conditions 6.2 Inborn Errors of Metabolism
7 GI Disorders & Food Allergy
7.1 Gastrointestinal Disorders: IBD, Celiac, Short Bowel & GERD 7.2 Food Allergy, FPIES & Eosinophilic Esophagitis
8 Body System & Organ Dysfunction
8.1 Cystic Fibrosis & Respiratory Support 8.2 Congenital Heart Disease & Cardiac Conditions 8.3 Chronic Kidney Disease, Dialysis & Transplant
9 Oncology, Endocrine & Weight-Related Care
9.1 Pediatric Oncology & HSCT Nutrition 9.2 Diabetes Management & Ketogenic Diet Therapy 9.3 Pediatric Overweight & Obesity (AAP 2023 Guideline) 9.4 Eating Disorders, ARFID & Pediatric Feeding Disorder
10 Clinical Status & Health History
10.1 Medical Treatment & Medication History 10.2 Nutrition & Supplementation History 10.3 Cultural & Psychosocial Factors 10.4 Activity & Lifestyle History 10.5 Birth, Perinatal & Surgical History
11 Anthropometrics & Growth Assessment
11.1 Anthropometric Measurement Techniques 11.2 Growth Charts & Z-Score Interpretation 11.3 Growth Assessment in Preterm & Special Populations 11.4 Pediatric Malnutrition: AND/ASPEN Consensus Criteria 11.5 Body Composition Assessment in Children
12 Physical Exam, Laboratory Data & Nutrition Diagnosis
12.1 Nutrition-Focused Physical Exam 12.2 Diagnostic & Laboratory Testing 12.3 Micronutrient Status Assessment & Deficiency Workup 12.4 Gastrointestinal Function & Diagnostic Testing 12.5 Nutrition Diagnosis, PES Statements & the NCP
13 Estimation of Nutritional Needs
13.1 Energy Needs Across Age & Clinical State 13.2 Protein & Fluid Requirements 13.3 Micronutrient Needs & Catch-Up Growth 13.4 Estimating Needs in Critical Illness & Special Clinical States
14 Oral Nutrition & Supplementation
14.1 Oral Nutrition & Therapeutic Diet Modification 14.2 Texture Modification & Dysphagia Management 14.3 Vitamin & Mineral Supplementation
15 Enteral Nutrition Support
15.1 Enteral Nutrition: Indications & Access 15.2 Enteral Formula Selection 15.3 Feeding Regimens, Advancement & Complications
16 Parenteral Nutrition Support
16.1 PN Indications & Composition 16.2 PN Initiation, Advancement & Monitoring 16.3 PN Complications & IFALD
17 Care Planning, Coordination & Education
17.1 Monitoring & Evaluation of Nutrition Care 17.2 Interdisciplinary Coordination & Transitions of Care 17.3 Access to Food & Healthcare: Federal Programs 17.4 Education & Counseling for Children & Families 17.5 Documentation, Quality & Outcomes in Pediatric Nutrition Care 17.6 Ethics, Palliative Care & Nutrition Decision-Making
9.1 Pediatric Oncology & HSCT Nutrition
Key Takeaways Explain This Topic AI
Cancer cachexia is a cytokine-driven, hypermetabolic state in which skeletal muscle is catabolized despite intake — feeding alone does not reverse it, unlike simple starvation.
Nutrition risk is highest with advanced solid tumors, ALL induction (steroids plus asparaginase), high-risk neuroblastoma, and HSCT.
The classic 'neutropenic diet' is not evidence-based; current practice emphasizes safe food handling rather than broad restriction of fresh fruits and vegetables.
Nasogastric enteral feeding is accepted, safe even during neutropenia, and should start early; PN is reserved for an unusable gut (severe mucositis, gut GVHD).
Asparaginase pancreatitis calls for a low-fat diet during and after the episode, and asparaginase can also cause hypertriglyceridemia and hyperglycemia.
Last updated: August 2026
Malnutrition in Pediatric Cancer
Malnutrition is common in children with cancer, both at diagnosis and during therapy. Prevalence varies by tumor type: roughly 5–10% of children with standard-risk acute lymphoblastic leukemia (ALL) are undernourished at diagnosis, compared with up to 50% of those with advanced or metastatic solid tumors. Overnutrition matters too — obesity at diagnosis is increasingly common and is independently associated with worse outcomes and more toxicity in ALL.
Cancer cachexia must be distinguished from simple starvation. Starvation is a protein-sparing, hypometabolic adaptation that reverses fully when feeding resumes. Cachexia is a hypermetabolic, inflammatory state driven by tumor-derived cytokines such as tumor necrosis factor-alpha and interleukin-6, in which skeletal muscle is catabolized despite adequate intake, and feeding alone does not reverse it. Because corticosteroids can preserve or increase weight through fat and fluid gain while muscle is lost, weight alone is a poor assessment tool; serial mid-upper arm circumference or triceps skinfold measurements give a better picture of lean mass.
Risk Stratification for Nutrition Support
- Higher nutrition risk Lower nutrition risk
- Advanced or metastatic solid tumors Standard-risk ALL in maintenance
- ALL induction (steroids + asparaginase) Low-stage localized tumors treated with surgery alone
- High-risk neuroblastoma, head and neck tumors Most brain tumors off active radiation
- Hematopoietic stem cell transplantation (HSCT), especially allogeneic
- Treatment-Related Nutrition Problems
Mucositis from chemotherapy and radiation causes painful oral and esophageal ulceration. Management includes meticulous oral care (soft brushing, saline or bicarbonate rinses), topical analgesia before meals, and texture modification — soft, moist, bland foods served cool; avoid acidic, spicy, salty, and coarse foods.
Nausea and vomiting are far better controlled in the modern antiemetic era (5-HT3 antagonists, NK1 antagonists), but anticipatory nausea and learned food aversions persist. Practical counseling: avoid serving favorite foods on chemotherapy days (to prevent aversion conditioning), offer small frequent meals, and prefer cold or room-temperature foods, which emit less odor.
Taste changes (dysgeusia), including a metallic taste, reduce intake; plastic utensils and alternate protein sources (eggs, dairy, poultry instead of red meat) help.
Neutropenia historically triggered the restrictive 'neutropenic diet' (no fresh fruits or vegetables, no salad bars). Controlled studies have shown no infection benefit from these broad restrictions, and major pediatric oncology centers now emphasize food safety rather than food-group restriction : thorough hand hygiene, safe food handling and storage, well-cooked meats and eggs, pasteurized dairy only, and avoidance of raw sprouts, unpasteurized products, and deli meats unless reheated until steaming.
Steroids, Asparaginase, and Methotrexate
Corticosteroids (prednisone, dexamethasone) in ALL induction cause hyperglycemia, intense appetite with rapid weight gain, myopathy, and bone loss. Counsel families on structured meals and planned snacks rather than unrestricted grazing.
Asparaginase can cause pancreatitis — during and after an episode, prescribe a low-fat diet (with pancreatic rest if severe). Asparaginase also causes hypertriglyceridemia (usually transient; severe elevations managed with a low-fat diet and rarely insulin or fibrates), hyperglycemia, coagulopathy, and hepatotoxicity.
Methotrexate is a folate antagonist that inhibits dihydrofolate reductase; after high-dose methotrexate, leucovorin (folinic acid) rescue protects normal cells. Know the concept that high-dose supplemental folate could theoretically blunt methotrexate's antileukemic effect — routine folate supplements are generally avoided during active methotrexate therapy.
Enteral and Parenteral Support
When oral intake cannot meet needs, nasogastric (NG) enteral feeding is accepted and safe , even during neutropenia and thrombocytopenia, and should be started early — before significant weight loss accrues — rather than as a last resort. A gastrostomy tube is considered when support will be prolonged (typically >3 months) and the child is stable enough for placement. Parenteral nutrition (PN) is reserved for a genuinely unusable gut: severe grade 3–4 mucositis with ileus, severe gut graft-versus-host disease (GVHD), or obstruction. Enteral feeding preserves gut integrity and carries a lower infection risk than PN.
HSCT-Specific Nutrition
Conditioning with high-dose chemotherapy with or without total body irradiation (TBI) makes mucositis nearly universal , and most allogeneic recipients require nutrition support. Acute gut GVHD presents with high-volume secretory diarrhea and cramping; management is stepwise: bowel rest with PN for severe disease, then gradual reintroduction of low-fiber, low-lactose, low-fat foods advanced as tolerated, with repletion of zinc and electrolytes lost in stool. Food safety precautions last for the duration of immunosuppression — often 6–12 months or longer if GVHD persists — not merely until neutrophil recovery. Vitamin D deficiency is common and should be monitored and supplemented. Important late effects include growth failure from growth hormone deficiency after TBI in young children and reduced bone mineral density; ensure adequate calcium, vitamin D, and weight-bearing activity.
Survivorship and Growth
Survivors of childhood cancer — especially ALL survivors treated with cranial irradiation and corticosteroids — carry elevated rates of obesity, insulin resistance, and metabolic syndrome. Long-term follow-up should include cardiometabolic screening and healthy-lifestyle counseling. Throughout active treatment, monitor weight, height, and BMI trajectory with the goals of preserving growth velocity, preventing undernutrition, and limiting excessive steroid-driven weight gain.